IKT•benzinga•
Inhibikase Therapeutics Q1 2024 GAAP EPS $(0.73) Beats $(0.79) Estimate, Cash $9.7M
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 16, 2024 by benzinga